Videos

PharmExec Interviews at Pharma Lalarukh Haris Shaikh 2022

PharmExec Interviews Agathe Le Lay at Pharma 2022

This segment conveys the importance of decentralizing clinical trials to increase diversity and serve all types of people in the United States, as well as the industry.  In addition, it touches on the importance of having diverse investigators to help recruit and communicate with all types of people.

Clinical Trials and Representation

“The nuance of language, and culture, and understanding” — what happened to the diversity of agency creative directors in the past 30 years? Only about 20% of creative directors are women, and at last count, there are only ten Black executive creative directors in the entire advertising industry from big holding companies, one with a healthcare focus.

The Messenger Matters 

The importance of data analytics can not be understated when putting together inclusive workforces. Bringing in and retaining top talent across all races is of the utmost importance to benefit all stakeholders, especially the patients. You have to have the right people “in the room” representing our diverse population.

Pharma Sales Team Demographics and Disease Prevalance in Different Races

The US is composed of tens of thousands of zip codes, and demographics and income levels can change dramatically within a five-mile radius. How are pharma companies addressing this reality?

Zip Codes and Health Equity 

Our panelists talk about preventative health messaging and dynamics of health of a specific group of people to help improve the lifespan of all people, especially the underserved minority populations. The segment also touches on structural racism factors like food deserts, “essential workers”, and holding doctors accountable.

Life Expectancy in Minorities - How Can Pharma React? 

Pharmaceutical Executive caught up with some industry experts at the Pharma USA conference in Philadelphia in April 2022. See what they had to say about leadership, drug development, pricing, and psychedelics in these brief video interviews.

Pharmaceutical Executive at Pharma USA

Among the topics discussed at Pharm Exec’s recent RWE roundtable are how the pandemic has served to validate the use of RWE/RWD; the most important features of a real-world data set; and key considerations when selecting an RWD partner. 

Pharmaceutical CEO Leadership: Real-World Evidence

In this segment, executives discuss the need to adjust to virtual and in-person, face-to-face interactions with both internal and external stakeholders.


Editorial Videos